Announcements

Job Offers

Top 5 -yesterday

Top 5 -last week

Top 5 -last month

PT: Grower receives authorization to begin preliminary cultivation operations in Portugal

Clever Leaves has received a pre-license letter from INFARMED I.P., the Portuguese regulatory authority with oversight over medical products, medical devices and cosmetics, including cannabis. The pre-license letter was granted to Northern Swan Portugal, Clever Leaves’ wholly-owned subsidiary, and confirms the company’s cannabis license application has successfully passed administrative review and complies with regulatory requirements for its proposed cannabis cultivation activities in Portugal.

"The pre-license evidences that the company has met INFARMED's requirements to begin preliminary operations, including importation of cannabis genetics and their cultivation," the team with the company explains. "Following successful completion of the next step in the licensing process, which consists of additional INFARMED facility inspections, the company is expected to receive a cannabis cultivation license allowing it to commercialize product."

“With a clear regulatory framework and the agronomical advantage for large-scale, efficient production, Portugal has the potential to become a leading region for cannabinoid research as well as one of the largest exporters of medical cannabis in Europe. Obtaining this pre-license affirms Clever Leaves’ expansion plan as a pioneering global medical cannabis producer and underscores our competitive advantage in developing sustainable, low-cost cannabis production capacity globally,” said Kyle Detwiler, CEO of Clever Leaves. “We commenced in Portugal with a climatic, hydrological and agricultural survey in 2018, which led to our final site and community selection. Over the past year, we assembled an executive team handpicked from leading Portuguese pharmaceutical and agricultural businesses, and our team has worked efficiently to identify and acquire a scalable property, complete an initial high quality facility, and meet the strict regulatory requirements in Portugal to provide patients with pharmaceutical-grade medical cannabis. We look forward to completing the next milestones in the licensing process.”

"To date, only four companies have received cannabis cultivation licenses in Portugal. Clever Leaves’ facility is being developed on 85 hectares of land. Once fully licensed, the first phase of the facility will consist of an existing 100,000 square foot greenhouse cultivating medical cannabis," they conclude. 

For more information:
Clever Leaves
info@cleverleaves.com   
cleverleaves.com    


Publication date:



Receive the daily newsletter in your email for free | Click here


Other news in this sector:


Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber